NDC 72579-125 – Tevimbra

Tislelizumab 10 mg/mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC72579-125

Product details

Brand name
Tevimbra
Generic name
Tislelizumab-jsgr
Labeler
BeOne Medicines USA, Inc.
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA761232
Marketed since
July 13, 2026
Listing expires
December 31, 2027
Pharmacologic class
Programmed Death Receptor-1 Blocking Antibody

Active ingredients

Uses, dosage, side effects and warnings for Tevimbra →

Package NDC codes (1)

Package NDCDescriptionSince
72579-125-001 VIAL, GLASS in 1 CARTON (72579-125-00) / 15 mL in 1 VIAL, GLASSJul 13, 2026

Other Tevimbra products